Alembic Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2025 ,inter alia, to consider and approve With reference to the ....
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has scheduled a Board meeting on 4th November 2025 to consider and approve its unaudited financial results for the second quarter and first half of FY26, both ending 30th September 2025. This is a routine regulatory intimation filed under SEBI listing requirements ahead of the results. The trading window for company securities has been closed since 1st October 2025 and will reopen 48 hours after the results are declared. No financial figures, segment performance, or guidance has been disclosed in this filing — those details will come on 4th November.
No immediate stock impact from this intimation itself. Investors should track the Q2/H1FY26 results on 4th November for actual revenue, profit, and margin trends. Until then, the stock is in a trading-window blackout period for insiders.